- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 22.2M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $118.01M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $117.57M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $183.65M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $100.02M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $167.24M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $169.28M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $285.99M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $287.86M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $987.98M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.03B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $996.63M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.04B |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $4.51M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $0 |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 20M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $357K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$149.16M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $850.76M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $405.33M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$7.38 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$7.38 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $80.8M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$147.54M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$152.04M |
| Revenue | Q1 2025 · Mar 31, 2024 | $0 |